317 related articles for article (PubMed ID: 18279310)
21. Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.
Rossi S; De Chiara V; Musella A; Cozzolino M; Bernardi G; Maccarrone M; Mercuri NB; Carrì MT; Centonze D
Amyotroph Lateral Scler; 2010; 11(1-2):83-90. PubMed ID: 19452308
[TBL] [Abstract][Full Text] [Related]
22. Degeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates.
Netzahualcoyotzi C; Tapia R
Acta Neuropathol Commun; 2015 May; 3():27. PubMed ID: 25968178
[TBL] [Abstract][Full Text] [Related]
23. AMPA receptor-mediated neuronal death in sporadic ALS.
Kwak S; Hideyama T; Yamashita T; Aizawa H
Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
[TBL] [Abstract][Full Text] [Related]
24. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
26. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?
Kawahara Y; Kwak S
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):131-44. PubMed ID: 16183555
[TBL] [Abstract][Full Text] [Related]
27. Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo.
Tovar-Y-Romo LB; Santa-Cruz LD; Zepeda A; Tapia R
Neurochem Int; 2009; 54(3-4):186-91. PubMed ID: 19100799
[TBL] [Abstract][Full Text] [Related]
28. GluR2 AMPA receptor subunit expression in motoneurons at low and high risk for degeneration in amyotrophic lateral sclerosis.
Laslo P; Lipski J; Nicholson LF; Miles GB; Funk GD
Exp Neurol; 2001 Jun; 169(2):461-71. PubMed ID: 11358459
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.
Martin LJ; Chang Q
Mol Neurobiol; 2012 Feb; 45(1):30-42. PubMed ID: 22072396
[TBL] [Abstract][Full Text] [Related]
30. Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons.
Jahn K; Grosskreutz J; Haastert K; Ziegler E; Schlesinger F; Grothe C; Dengler R; Bufler J
Neuroscience; 2006 Nov; 142(4):1019-29. PubMed ID: 16949760
[TBL] [Abstract][Full Text] [Related]
31. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2.
Bogaert E; Van Damme P; Poesen K; Dhondt J; Hersmus N; Kiraly D; Scheveneels W; Robberecht W; Van Den Bosch L
Neurobiol Aging; 2010 Dec; 31(12):2185-91. PubMed ID: 19185395
[TBL] [Abstract][Full Text] [Related]
32. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1.
Yang Y; Gozen O; Vidensky S; Robinson MB; Rothstein JD
Glia; 2010 Feb; 58(3):277-86. PubMed ID: 19672971
[TBL] [Abstract][Full Text] [Related]
34. PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons.
Yang DJ; Wang XL; Ismail A; Ashman CJ; Valori CF; Wang G; Gao S; Higginbottom A; Ince PG; Azzouz M; Xu J; Shaw PJ; Ning K
Cell Death Dis; 2014 Feb; 5(2):e1096. PubMed ID: 24577094
[TBL] [Abstract][Full Text] [Related]
35. Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration.
Rainey-Smith SR; Andersson DA; Williams RJ; Rattray M
J Neurochem; 2010 May; 113(3):692-703. PubMed ID: 20132465
[TBL] [Abstract][Full Text] [Related]
36. The role of AMPA receptors and VEGF in ALS.
Van Damme P
Verh K Acad Geneeskd Belg; 2009; 71(4):241-50. PubMed ID: 20084835
[TBL] [Abstract][Full Text] [Related]
37. Differences in ionotropic glutamate receptor subunit expression are not responsible for strain-dependent susceptibility to excitotoxin-induced injury.
Schauwecker PE
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):70-81. PubMed ID: 12670704
[TBL] [Abstract][Full Text] [Related]
38. Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo.
Corona JC; Tapia R
Neuropharmacology; 2007 Apr; 52(5):1219-28. PubMed ID: 17320918
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
[TBL] [Abstract][Full Text] [Related]
40. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice.
Morrison BM; Janssen WG; Gordon JW; Morrison JH
J Comp Neurol; 1998 Jun; 395(4):523-34. PubMed ID: 9619504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
